AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Bulterys, M Burchett, SK Culnane, M Cunningham-Schrader, B Dominguez, K Dunkle, L Draper, L Fowler, MG Hanson, C Kpamegan, E Lindegren, ML Martin-Carpenter, L McIntosh, K McNamara, J McSherry, G Mitchell, WG Mofenson, LM Oleske, JM Rhodes, P Shapiro, DE Smith, ME Styrt, B
Citation: M. Bulterys et al., Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts, J ACQ IMM D, 25(3), 2000, pp. 261-268

Authors: Hughes, WT Shenep, JL Rodman, JH Fridland, A Willoughby, R Blanchard, S Purdue, L Coakley, DF Cundy, KC Culnane, M Zimmer, B Burchett, S Read, JS
Citation: Wt. Hughes et al., Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type1, ANTIM AG CH, 44(4), 2000, pp. 1041-1046

Authors: Frenkel, LM Capparelli, EV Dankner, WM Xu, J Smith, IL Ballow, A Culnane, M Read, JS Thompson, M Mohan, KM Shaver, A Robinson, CA Stempien, MJ Burchett, SK Melvin, AJ Borkowsky, W Petru, A Kovacs, A Yogev, R Goldsmith, J McFarland, EJ Spector, SA
Citation: Lm. Frenkel et al., Oral ganciclovir in children: Pharmacokinetics, safety, tolerance, and antiviral effects, J INFEC DIS, 182(6), 2000, pp. 1616-1624

Authors: Hanson, IC Antonelli, TA Sperling, RS Oleske, JM Cooper, E Culnane, M Fowler, MG Kalish, LA Lee, SS McSherry, G Mofenson, L Shapiro, DE
Citation: Ic. Hanson et al., Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatalexposure to zidovudine, J ACQ IMM D, 20(5), 1999, pp. 463-467

Authors: Culnane, M Fowler, MG Oleske, J
Citation: M. Culnane et al., Infant growth after in utero exposure to zidovudine - Reply, J AM MED A, 282(6), 1999, pp. 528-529

Authors: Culnane, M Fowler, M Lee, SS McSherry, G Brady, M O'Donnell, K Mofenson, L Gortmaker, SL Shapiro, DE Scott, G Jimenez, E Moore, EC Diaz, C Flynn, PM Cunningham, B Oleske, J
Citation: M. Culnane et al., Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women, J AM MED A, 281(2), 1999, pp. 151-157

Authors: Kline, MW Van Dyke, RB Lindsey, JC Gwynne, M Culnane, M Diaz, C Yogev, R McKinney, RE Abrams, EJ Mofenson, LM
Citation: Mw. Kline et al., Combination therapy with stavudine (d47) plus didanosine (ddI) in childrenwith human immunodeficiency virus infection, PEDIATRICS, 103(5), 1999, pp. E621-E626

Authors: Kline, MW Blanchard, S Fletcher, CV Shenep, JL McKinney, RE Brundage, RC Culnane, M Van Dyke, RB Dankner, WM Kovacs, A McDowell, JA Hetherington, S
Citation: Mw. Kline et al., A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection, PEDIATRICS, 103(4), 1999, pp. E471-E475

Authors: McSherry, GD Shapiro, DE Coombs, RW McGrath, N Frenkel, LM Britto, P Culnane, M Sperling, RS
Citation: Gd. Mcsherry et al., The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076), J PEDIAT, 134(6), 1999, pp. 717-724
Risultati: 1-9 |